Total Payments
$15,800
2024 Payments
$415.91
Companies
55
Transactions
648
Medicare Patients
1,725
Medicare Billing
$248,564
Payment Breakdown by Category
Food & Beverage$11,169 (70.7%)
Other$4,400 (27.8%)
Education$171.43 (1.1%)
Gifts$59.40 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,169 | 619 | 70.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4,400 | 17 | 27.8% |
| Education | $171.43 | 11 | 1.1% |
| Gift | $59.40 | 1 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Tandem Diabetes Care, Inc. | $4,435 | 19 | $0 (2020) |
| Novo Nordisk Inc | $1,521 | 79 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $1,365 | 58 | $0 (2020) |
| Mannkind Corporation | $1,124 | 62 | $0 (2024) |
| Merz North America, Inc. | $763.14 | 6 | $0 (2023) |
| Insulet Corporation | $753.88 | 60 | $0 (2024) |
| Allergan, Inc. | $747.66 | 46 | $0 (2022) |
| Amgen Inc. | $598.20 | 42 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $445.36 | 24 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $386.53 | 21 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $415.91 | 20 | Mannkind Corporation ($118.46) |
| 2023 | $477.37 | 26 | ABBVIE INC. ($102.37) |
| 2022 | $658.36 | 32 | Mannkind Corporation ($137.60) |
| 2021 | $911.28 | 29 | MERZ NORTH AMERICA, INC. ($428.77) |
| 2020 | $5,005 | 47 | Tandem Diabetes Care, Inc. ($4,418) |
| 2019 | $2,286 | 133 | Novo Nordisk Inc ($365.29) |
| 2018 | $2,886 | 178 | AstraZeneca Pharmaceuticals LP ($396.57) |
| 2017 | $3,159 | 183 | AstraZeneca Pharmaceuticals LP ($710.04) |
All Payment Transactions
648 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/05/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $19.95 | General |
| Category: Insulin Pump | ||||||
| 11/25/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $18.95 | General |
| 11/21/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $15.23 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 11/12/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $40.61 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/07/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: Insulin Pump | ||||||
| 10/31/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DIABETES MEDICINE | ||||||
| 10/08/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $17.92 | General |
| 09/26/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: DIABETES MEDICINE | ||||||
| 09/19/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Endocrinology | ||||||
| 08/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Diabetes Care | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.31 | General |
| Category: DIABETES | ||||||
| 06/11/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.75 | General |
| 04/03/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $25.66 | General |
| 03/27/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.94 | General |
| 02/15/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 02/01/2024 | Ascensia Diabetes Care Us Inc. | EVERSENSE E3 SENSOR KIT - RETAIL (Device) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Diabetes | ||||||
| 01/25/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: Insulin Pump | ||||||
| 01/11/2024 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: DIABETES MEDICINE | ||||||
| 12/15/2023 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: Insulin Pump | ||||||
| 12/07/2023 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $21.91 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/14/2023 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $13.15 | General |
| 09/21/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Endocrinology | ||||||
| 09/14/2023 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: DIABETES MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 304 | 639 | $99,400 | $50,248 |
| 2022 | 4 | 358 | 703 | $113,175 | $58,946 |
| 2021 | 4 | 342 | 742 | $113,875 | $58,737 |
| 2020 | 7 | 721 | 1,225 | $154,533 | $80,633 |
Total Patients
1,725
Total Services
3,309
Medicare Billing
$248,564
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 523 | $78,450 | $37,006 | 47.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 83 | 98 | $19,600 | $12,761 | 65.1% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 12 | 18 | $1,350 | $482.24 | 35.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 231 | 556 | $83,400 | $41,046 | 49.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 92 | 107 | $21,550 | $14,690 | 68.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $6,650 | $2,649 | 39.8% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2022 | 16 | 21 | $1,575 | $560.78 | 35.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 268 | 622 | $93,300 | $47,209 | 50.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 40 | 64 | $12,800 | $8,255 | 64.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $4,550 | $2,058 | 45.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 21 | 43 | $3,225 | $1,216 | 37.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 295 | 746 | $111,853 | $61,317 | 54.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 93 | 107 | $21,400 | $11,309 | 52.8% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 23 | 23 | $8,050 | $3,608 | 44.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 67 | 99 | $7,425 | $2,761 | 37.2% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 122 | 125 | $3,750 | $1,190 | 31.7% |
| 82947 | Blood glucose (sugar) level | Office | 2020 | 86 | 89 | $1,335 | $342.65 | 25.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 35 | 36 | $720.00 | $105.84 | 14.7% |
About Dr. David Feinstein, MD
Dr. David Feinstein, MD is a Specialist healthcare provider based in Dallas, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609888965.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Feinstein, MD has received a total of $15,800 in payments from pharmaceutical and medical device companies, with $415.91 received in 2024. These payments were reported across 648 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($11,169).
As a Medicare-enrolled provider, Feinstein has provided services to 1,725 Medicare beneficiaries, totaling 3,309 services with total Medicare billing of $248,564. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Dallas, TX
- Active Since 08/13/2006
- Last Updated 07/29/2025
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1609888965
Products in Payments
- t:slim X2 insulin pump (Device) $4,418
- FARXIGA (Drug) $1,186
- AFREZZA (Drug) $1,124
- Omnipod (Device) $753.88
- Ozempic (Drug) $508.69
- V-GO (Device) $348.32
- Victoza (Drug) $325.07
- PRALUENT ALIROCUMAB INJECTION (Biological) $319.67
- BOTOX (Biological) $280.23
- Repatha (Biological) $270.47
- INVOKANA (Drug) $255.75
- Saxenda (Drug) $236.49
- Tresiba (Drug) $225.36
- Prolia (Biological) $214.41
- CYCLOSET (Drug) $186.88
- BD Nano (Device) $159.37
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $156.86
- NATPARA (Drug) $144.23
- Minimed 670G System (Device) $139.99
- JARDIANCE (Drug) $131.11
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Dallas
Dr. William Lumry, M.d, M.D
Specialist — Payments: $2.4M
Specialist $2.4M
Dr. Roy Fleischmann, M.d, M.D
Specialist — Payments: $1.6M
Specialist $1.6M
Dr. Marc Tribble, M.d, M.D
Specialist — Payments: $763,573
Specialist $763,573
Stephen Hohmann, Md, MD
Specialist — Payments: $551,635
Specialist $551,635
Dr. William Adams, M.d, M.D
Specialist — Payments: $350,194
Specialist $350,194
Clinton Bell, M.d, M.D
Specialist — Payments: $273,947
Specialist $273,947